Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
PLoS One
    January 2025
  1. CONNIE T, Aderinola TB, Ong JY, Ong TS, et al
    Parkinson's disease screening using a fusion of gait point cloud and silhouette features.
    PLoS One. 2025;20:e0315453.
    >> Share

  2. SONG H, Ge S, Li J, Jiao C, et al
    Effects of aerobic and resistance training on walking and balance abilities in older adults with Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314539.
    >> Share

  3. GRAHAM L, Vitorio R, Walker R, Godfrey A, et al
    Digital measurement of ocular microtremor in Parkinson's disease: Protocol for a pilot study to assess reliability and clinical validation.
    PLoS One. 2025;20:e0313452.
    >> Share

  4. YU B, Zhang H, Zhang M
    Deep learning-based differential gut flora for prediction of Parkinson's.
    PLoS One. 2025;20:e0310005.
    >> Share

  5. ZHANG L, Jiang Y, Fan W, Xue H, et al
    Unveiling the efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: A comprehensive review of systematic analyses.
    PLoS One. 2025;20:e0313420.
    >> Share

  6. RUKAVINA K, Staunton J, Zinzalias P, Krbot Skoric M, et al
    Wearable devices may aid the recognition of fluctuation-related pain in Parkinson's disease-An exploratory, cross-sectional analysis of two prospective observational studies.
    PLoS One. 2025;20:e0316563.
    >> Share

  7. LEE J, Kang SH, Koh SB
    Postural instability and gait disturbance are associated with abnormal stereopsis in Parkinson's disease.
    PLoS One. 2025;20:e0317935.
    >> Share

  8. LU H, Qi G, Wu D, Lin C, et al
    A novel feature extraction method based on dynamic handwriting for Parkinson's disease detection.
    PLoS One. 2025;20:e0318021.
    >> Share

  9. KIM J, Kim R, Byun K, Kang N, et al
    Assessment of temporospatial and kinematic gait parameters using human pose estimation in patients with Parkinson's disease: A comparison between near-frontal and lateral views.
    PLoS One. 2025;20:e0317933.
    >> Share

  10. DE ALMEIDA SB, Tavares Sobreira ES, de Lucena Alves CP, Lima DP, et al
    Effect of power training on physical functional performance of patients with Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0314058.
    >> Share

  11. GERMANI E, Bhagwat N, Dugre M, Gau R, et al
    Predicting Parkinson's disease trajectory using clinical and functional MRI features: A reproduction and replication study.
    PLoS One. 2025;20:e0317566.
    >> Share

  12. BECK EN, Wang MTY, Intzandt BN, Almeida QJ, et al
    Correction: Sensory focused exercise improves anxiety in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2025;20:e0319768.
    >> Share


  13. Retraction: TOM40 Mediates Mitochondrial Dysfunction Induced by alpha-Synuclein Accumulation in Parkinson's Disease.
    PLoS One. 2025;20:e0319935.
    >> Share

  14. ABOELZAHAB YH, Bojmehrani A, Ahmed YE, Boon H, et al
    Psychological stress associated with prognostic uncertainties in recently diagnosed Parkinson's disease patients: A qualitative study.
    PLoS One. 2025;20:e0319576.
    >> Share

  15. GOMEZ LF, Morales A, Fierrez J, Orozco-Arroyave JR, et al
    Correction: Exploring facial expressions and action unit domains for Parkinson detection.
    PLoS One. 2025;20:e0320872.
    >> Share


  16. Retraction: Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
    PLoS One. 2025;20:e0321152.
    >> Share

  17. HUO H, Jiao S, Li D, Ma L, et al
    Efficient quantification of Parkinson's disease severity using augmented time-series data.
    PLoS One. 2025;20:e0319826.
    >> Share

  18. SANTOS-GARCIA D, Gonzalez-Ortega G, Sanchez-Alonso P, Planas-Ballve A, et al
    Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study.
    PLoS One. 2025;20:e0316052.
    >> Share

  19. ESTIVALET KM, Pettenuzzo TSA, Mazzilli NL, Ferreira LF, et al
    The use of brain-machine interface, motor imagery, and action observation in the rehabilitation of individuals with Parkinson's disease: A protocol study for a randomized clinical trial.
    PLoS One. 2025;20:e0315148.
    >> Share

  20. HODGSON P, Jordan A, Sinani C, Charura D, et al
    The relationship between physical function and psychological symptoms in Parkinson's: Perceptions of People with Parkinson's and Carers.
    PLoS One. 2025;20:e0310578.
    >> Share

  21. KIM J, Park S, Lee JH, Lee JY, et al
    Zinc finger protein 184 prevents alpha-synuclein preformed fibril-mediated neurodegeneration through the interleukin enhancer binding factor 3-microRNA-7 pathway.
    PLoS One. 2025;20:e0323279.
    >> Share

  22. OKAI T, Sato S, Deshpande M, Matsumoto SI, et al
    AAV delivery of GBA1 suppresses alpha-synuclein accumulation in Parkinson's disease models and restores functions in Gaucher's disease models.
    PLoS One. 2025;20:e0321145.
    >> Share

  23. ABAQUITA TAL, Damulewicz M, Pyza E
    The neuroprotective role of CncC in a Drosophila model of Parkinson's disease.
    PLoS One. 2025;20:e0322640.
    >> Share

  24. GORENFLO MP, Gao Z, Davis PB, Kaelber D, et al
    Amphetamine use and Parkinson's disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
    PLoS One. 2025;20:e0323761.
    >> Share

  25. LI Y, Jia W, Chen C, Chen C, et al
    Identification of biomarkers associated with inflammatory response in Parkinson's disease by bioinformatics and machine learning.
    PLoS One. 2025;20:e0320257.
    >> Share

  26. ORAYJ K
    Trends in Parkinson's disease medication prescribing patterns in the UK: An interrupted time series analysis (2019-2024).
    PLoS One. 2025;20:e0324999.
    >> Share

  27. MENDORF S, Heimrich KG, Muhlhammer HM, Schonenberg A, et al
    The influence of the Big Five inventory on quality of life in people with Parkinson's disease aged 50 and above: A Longitudinal Analysis from the Survey of Health, Aging and Retirement in Europe (SHARE).
    PLoS One. 2025;20:e0322089.
    >> Share

  28. LANDER JJ, Moran MF, Alexanian HR
    Correlations of gait kinematics and cognitive skills in Parkinson disease.
    PLoS One. 2025;20:e0317389.
    >> Share

  29. IBRAHIM MK, Mohammed SI, Al-Gawwam GAAS
    Neurologists' perspectives on management challenges and mitigation strategies for Parkinson's disease patients: A qualitative study in Iraq.
    PLoS One. 2025;20:e0326851.
    >> Share

  30. YADAV R, Dey S, Kumar R, Mohanan AP, et al
    Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented population.
    PLoS One. 2025;20:e0325624.
    >> Share

  31. BSOUL R, Simonsen AH, Frederiksen KS, Svenstrup K, et al
    Seeding amplification assay with Universal Control Fluid: Standardized detection of alpha-synucleinopathies.
    PLoS One. 2025;20:e0326568.
    >> Share

  32. LIU T, Li J, Zhang J, Wei J, et al
    Cuproptosis-related genes associated with mitochondrial dysfunction in Parkinson's disease.
    PLoS One. 2025;20:e0327550.
    >> Share

  33. ZHU Z, Wu E, Leng P, Sun J, et al
    Finger drawing on smartphone screens enables early Parkinson's disease detection through hybrid 1D-CNN and BiGRU deep learning architecture.
    PLoS One. 2025;20:e0327733.
    >> Share

  34. CARAPELLOTTI AM, Rodger M, Doumas M
    Evaluating the short-term effects of dance on motor and non-motor outcomes in people living with Parkinson's: A crossover study.
    PLoS One. 2025;20:e0328293.
    >> Share

  35. KIM A, Schweighofer N, Petzinger GM, Finley JM, et al
    Uncovering locomotor learning dynamics in people with Parkinson's disease.
    PLoS One. 2025;20:e0326692.
    >> Share

  36. PAMLENYI K, Ferreira B, Regdon G Jr, Kristo K, et al
    Development and characterization of pramipexole dihydrochloride buccal films for Parkinson's disease treatment.
    PLoS One. 2025;20:e0329142.
    >> Share

  37. JOINEAU K, Harroch E, Boussac M, Fabbri M, et al
    Effect of foot reflexology on chronic pain in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2025;20:e0327865.
    >> Share

  38. WANG H, Feng L, He L, Liu N, et al
    Bioinformatics analysis to explore biomarkers and mechanisms of action associated with endoplasmic reticulum stress and ferroptosis in Parkinson's disease.
    PLoS One. 2025;20:e0328682.
    >> Share

  39. POLINSKI NK, Puolivali J, Rauhala L, Stenius TK, et al
    Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson's disease-related phenotypes in a novel humanized rat model.
    PLoS One. 2025;20:e0329823.
    >> Share

  40. KASEMSAP N, Tikkapanyo P, Wanjantuk P, Vorasoot N, et al
    Screening for Parkinson's disease using "computer vision".
    PLoS One. 2025;20:e0330373.
    >> Share

  41. UMEMURA A, Sato K, Iwamuro H, Uchiyama S, et al
    Effects of transcranial direct current stimulation using a commercially available device on gait in Parkinson's disease with freezing of gait.
    PLoS One. 2025;20:e0330286.
    >> Share

  42. LARSSON V, Hall S, Blennow K, Hansson O, et al
    Olfactory dysfunction and amyloid-positivity in Parkinson's disease-longitudinal analysis of cognitive decline and cerebrospinal fluid markers.
    PLoS One. 2025;20:e0325560.
    >> Share

  43. PAPIC E, Racki V, Hero M, Zimani AN, et al
    Microbial diversity in drug-naive Parkinson's disease patients.
    PLoS One. 2025;20:e0328761.
    >> Share

  44. NOROUZI-GHAZBI S, Mirbaha S, Li Z, Andrysek J, et al
    Gamification-based tele-rehabilitation for physical therapy in patients with Parkinson's disease: A scoping review.
    PLoS One. 2025;20:e0326705.
    >> Share


  45. Expression of Concern: The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling.
    PLoS One. 2025;20:e0330958.
    >> Share

    January 2024
  46. KIM M, Kim D, Kang H, Park S, et al
    A machine learning model for prediction of sarcopenia in patients with Parkinson's Disease.
    PLoS One. 2024;19:e0296282.
    >> Share

  47. BRUNI F, Mancuso V, Stramba-Badiale C, Stramba-Badiale M, et al
    Beyond traditional training: Integrating data from semi-immersive VR dual-task intervention in Parkinsonian Syndromes. A study protocol.
    PLoS One. 2024;19:e0294199.
    >> Share

  48. SOKOLOWSKI A, Bhagwat N, Chatelain Y, Dugre M, et al
    Longitudinal brain structure changes in Parkinson's disease: A replication study.
    PLoS One. 2024;19:e0295069.
    >> Share

  49. ESSAWY ESSAWY A, Abou-ElNaga OA, Mehanna RA, Badae NM, et al
    Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.
    PLoS One. 2024;19:e0296297.
    >> Share

  50. WAWRZICZNY E, Flinois B, Constant E, Brugalle E, et al
    Dealing with the diagnosis of Parkinson's disease and its implications for couple functioning in the early stage: An interpretative phenomenological analysis.
    PLoS One. 2024;19:e0294240.
    >> Share

  51. MEIJER LL, Ruis C, Schielen ZA, Dijkerman HC, et al
    CT-optimal touch and chronic pain experience in Parkinson's Disease; An intervention study.
    PLoS One. 2024;19:e0298345.
    >> Share

  52. TIAN J, Zuo C, Shi J, Ma D, et al
    Peripheral immune cell traits and Parkinson's disease: A Mendelian randomization study.
    PLoS One. 2024;19:e0299026.
    >> Share

  53. MALAGUTI MC, Gios L, Giometto B, Longo C, et al
    Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research study.
    PLoS One. 2024;19:e0300127.
    >> Share

  54. VARGA I, Bakstein E, Gilmore G, May J, et al
    Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology.
    PLoS One. 2024;19:e0298320.
    >> Share

  55. SEUTHE J, Heinzel A, Hulzinga F, Ginis P, et al
    Towards a better understanding of anticipatory postural adjustments in people with Parkinson's disease.
    PLoS One. 2024;19:e0300465.
    >> Share

  56. SCHRAG A, Kostev K
    Association of antihypertensives and Parkinson's disease in a primary care population matched for underlying diagnosis.
    PLoS One. 2024;19:e0299985.
    >> Share

  57. CAI X, Jin Z, Zhang S, Liu J, et al
    Sjogren's syndrome and Parkinson's Disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298778.
    >> Share

  58. MCMAHON L, McGrath D, Blake C, Lennon O, et al
    Responsiveness of respiratory function in Parkinson's Disease to an integrative exercise programme: A prospective cohort study.
    PLoS One. 2024;19:e0301433.
    >> Share

  59. SAADULLAH M, Tariq H, Chauhdary Z, Saleem U, et al
    Biochemical properties and biological potential of Syzygium heyneanum with antiparkinson's activity in paraquat induced rodent model.
    PLoS One. 2024;19:e0298986.
    >> Share

  60. KHAN A, Ezeugwa J, Ezeugwu VE
    A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson's disease.
    PLoS One. 2024;19:e0293382.
    >> Share

  61. SONG J, Li J, Pei X, Chen J, et al
    Identification of cuproptosis-realated key genes and pathways in Parkinson's disease via bioinformatics analysis.
    PLoS One. 2024;19:e0299898.
    >> Share

  62. ANJUM R, Raza C, Faheem M, Ullah A, et al
    Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson's disease through anti-oxidant capacities.
    PLoS One. 2024;19:e0302102.
    >> Share

  63. MORACA GAG, Orcioli-Silva D, Legutke BR, Gutierrez PP, et al
    Aerobic exercise on the treadmill combined with transcranial direct current stimulation on the gait of people with Parkinson's disease: A protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0300243.
    >> Share

  64. VARGA I, Bakstein E, Gilmore G, May J, et al
    Correction: Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology.
    PLoS One. 2024;19:e0302985.
    >> Share

  65. TABARI F, Berger JI, Flouty O, Copeland B, et al
    Speech, voice, and language outcomes following deep brain stimulation: A systematic review.
    PLoS One. 2024;19:e0302739.
    >> Share

  66. ZHANG HW, Xie J, Peng HC, Lin YS, et al
    Use of antiviral drugs and incidence of Parkinson's disease in Taiwan.
    PLoS One. 2024;19:e0302383.
    >> Share

  67. PARK MS, Park S, Kang JY, Jung IC, et al
    The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
    PLoS One. 2024;19:e0303156.
    >> Share

  68. ALTHAM C, Zhang H, Pereira E
    Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.
    PLoS One. 2024;19:e0303644.
    >> Share

  69. MILDNER S, Hotz I, Kubler F, Rausch L, et al
    Effects of activity-oriented physiotherapy with and without eye movement training on dynamic balance, functional mobility, and eye movements in patients with Parkinson's disease: An assessor-blinded randomised controlled pilot trial.
    PLoS One. 2024;19:e0304788.
    >> Share

  70. HARRIS DM, O'Bryan SJ, Latella C
    Non-invasive brain stimulation as treatment for motor impairment in people with Parkinson's disease: Protocol for an umbrella review.
    PLoS One. 2024;19:e0304717.
    >> Share

  71. AGLEY L, Hartley P, Lafortune L
    Exploring the experiences, priorities and preferences of people living with Parkinson's on exercise and physical activity promotion in the UK.
    PLoS One. 2024;19:e0304223.
    >> Share

  72. CRIGHTON EJ, Ouedraogo AM, Sawada M, Mestre TA, et al
    Patterns and determinants of health care utilization among people with Parkinson's disease: A population-based analysis in Ontario, Canada.
    PLoS One. 2024;19:e0305062.
    >> Share

  73. YALCIN M, Peralta AR, Bentes C, Silva C, et al
    Molecular characterization of the circadian clock in patients with Parkinson's disease-CLOCK4PD Study protocol.
    PLoS One. 2024;19:e0305712.
    >> Share

  74. GORJI A, Fathi Jouzdani A
    Machine learning for predicting cognitive decline within five years in Parkinson's disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers.
    PLoS One. 2024;19:e0304355.
    >> Share

  75. BOSCH-BARCELO P, Climent-Sanz C, Martinez-Navarro O, Masbernat-Almenara M, et al
    A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Study protocol for a randomized controlled trial.
    PLoS One. 2024;19:e0307304.
    >> Share

  76. WANG K, Han C, Yang J, Xu W, et al
    Benfotiamine protects MPTP-induced Parkinson's disease mouse model via activating Nrf2 signaling pathway.
    PLoS One. 2024;19:e0307012.
    >> Share

  77. STEINBACH S, Molina M, Grinberg LT, Aring L, et al
    Don't die like me: Which proteins are responsible for the selective neuronal vulnerability within the substantia nigra?
    PLoS One. 2024;19:e0296730.
    >> Share

  78. FUNG KW, Baye F, Baik SH, McDonald CJ, et al
    Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees.
    PLoS One. 2024;19:e0309222.
    >> Share

  79. USAMI N, Maegawa H, Hayashi M, Kudo C, et al
    Changes in the analgesic mechanism of oxytocin can contribute to hyperalgesia in Parkinson's disease model rats.
    PLoS One. 2024;19:e0300081.
    >> Share

  80. THIES T, Barbe MT, Mucke D
    Prosody matters: Preserved prominence marking strategies in people with Parkinson's disease independent of motor status.
    PLoS One. 2024;19:e0308655.
    >> Share

  81. PETERSEN I, Godec A, Ranjbarian F, Hofer A, et al
    A charged tail on anti-alpha-Synuclein antibodies does not enhance their affinity to alpha-Synuclein fibrils.
    PLoS One. 2024;19:e0308521.
    >> Share

  82. MORAES IAP, Collett J, Silva TDD, Franssen M, et al
    Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson's disease, results from a phase II randomised controlled trial.
    PLoS One. 2024;19:e0309217.
    >> Share

  83. RAMIREZ J, Saleh IG, Yanagawa ESK, Shimogawa M, et al
    Multivalency drives interactions of alpha-synuclein fibrils with tau.
    PLoS One. 2024;19:e0309416.
    >> Share

  84. XU N, Xing S, Li J, Pang B, et al
    Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.
    PLoS One. 2024;19:e0296424.
    >> Share

  85. MINNELLA A, McCusker KP, Amagata A, Trias B, et al
    Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease.
    PLoS One. 2024;19:e0309893.
    >> Share

  86. LIU K, An J, Zhang J, Zhao J, et al
    Network pharmacology combined with experimental validation show that apigenin as the active ingredient of Campsis grandiflora flower against Parkinson's disease by inhibiting the PI3K/AKT/NF-kappaB pathway.
    PLoS One. 2024;19:e0311824.
    >> Share

  87. HERATH HMMTB, Wijayawardhana KWSM, Wickramarachchi UI, Senanayake S, et al
    Impulse control disorders and other non-motor symptoms in Sri Lankan patients with Parkinson's disease.
    PLoS One. 2024;19:e0312342.
    >> Share

  88. SAIBENE FL, Agliardi C, Salvatore A, Arcuri P, et al
    Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial.
    PLoS One. 2024;19:e0309405.
    >> Share

  89. NOMOTO M, Tsuboi Y, Kashihara K, Chiu SW, et al
    Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST.
    PLoS One. 2024;19:e0309297.
    >> Share

  90. PARK S, Lee J, Kim JY, Park JH, et al
    Clinical significance of MRI-measured olfactory bulb height as an imaging biomarker of idiopathic Parkinson's disease.
    PLoS One. 2024;19:e0312728.
    >> Share

  91. MOHD AMIN NI, Mohd Nordin NA, Ismail A, Pillai SGK, et al
    A single-blind, randomised control trial on the effectiveness of a structured multi component training module for family caregiver of persons with Parkinson's disease: A study protocol.
    PLoS One. 2024;19:e0309648.
    >> Share

  92. WANG Z, Xia H, Ding Y, Lu R, et al
    No association between genetically predicted vitamin D levels and Parkinson's disease.
    PLoS One. 2024;19:e0313631.
    >> Share

  93. KHAN A, Ullah F, Alkreathy HM, Ahmed M, et al
    Phytochemical screening, antioxidant and anti-Parkinson activities of Berula erecta: A novel medicinal plant.
    PLoS One. 2024;19:e0305751.
    >> Share

  94. REGAN EW, Burnitz O, Hightower J, Dobner L, et al
    Rock Steady Boxing: A qualitative evaluation of a community exercise program for people with Parkinson's disease.
    PLoS One. 2024;19:e0309522.
    >> Share

  95. NAGY NS, Helal M, Alsawy ES, Ali MM, et al
    Paracentrotus lividus sea urchin gonadal extract mitigates neurotoxicity and inflammatory signaling in a rat model of Parkinson's disease.
    PLoS One. 2024;19:e0315858.
    >> Share

  96. CARMICHAEL-LOWE A, Fleming B, Reddy K, Wiseman J, et al
    Enhanced detection of distinct honeycomb-structured neuronal SMARCC2 cytobodies in Parkinson's Disease via Cyclic Heat-Induced Epitope Retrieval (CHIER).
    PLoS One. 2024;19:e0315183.
    >> Share


  97. Retraction: GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model.
    PLoS One. 2024;19:e0314546.
    >> Share

  98. HODGSON P, Jordan A, Sinani C, Charura D, et al
    Psycho-physical interactions in Parkinson's Disease: Protocol for a prospective observational cohort study.
    PLoS One. 2024;19:e0315345.
    >> Share

  99. SHIM SR, Kim JY, Kwon KY, Shin J, et al
    Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0310900.
    >> Share

  100. SAADULLAH M, Sehar A, Chauhdary Z, Siddique R, et al
    Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
    PLoS One. 2024;19:e0311140.
    >> Share

  101. LI T, Guo J
    Identifying the NEAT1/miR-26b-5p/S100A2 axis as a regulator in Parkinson's disease based on the ferroptosis-related genes.
    PLoS One. 2024;19:e0316179.
    >> Share

  102. PINTO C, Simon Myra R, Severo do Pinho A, Pereira F, et al
    Quality assessment and umbrella review of systematic reviews about dance for people with Parkinson's disease.
    PLoS One. 2024;19:e0311003.
    >> Share

    January 2023
  103. CHUNG JW, Knight CA, Bower AE, Martello JP, et al
    Rate control deficits during pinch grip and ankle dorsiflexion in early-stage Parkinson's disease.
    PLoS One. 2023;18:e0282203.
    >> Share

  104. CARVAJAL-OLIVEROS A, Dominguez-Baleon C, Sanchez-Diaz I, Zambrano-Tipan D, et al
    Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment.
    PLoS One. 2023;18:e0282348.
    >> Share

  105. ALI DE, Bassam SM, Elatrebi S, Habiba ES, et al
    HR LC-MS/MS metabolomic profiling of Yucca aloifolia fruit and the potential neuroprotective effect on rotenone-induced Parkinson's disease in rats.
    PLoS One. 2023;18:e0282246.
    >> Share

  106. TAN QY, Roberts HC, Fraser SDS, Amar K, et al
    What are the modifiable factors of treatment burden and capacity among people with Parkinson's disease and their caregivers: A qualitative study.
    PLoS One. 2023;18:e0283713.
    >> Share

  107. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    Prevalence and nature of self-reported visual complaints in people with Parkinson's disease-Outcome of the Screening Visual Complaints questionnaire.
    PLoS One. 2023;18:e0283122.
    >> Share

  108. HWANG KS, Langley J, Tripathi R, Hu XP, et al
    In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
    PLoS One. 2023;18:e0282684.
    >> Share

  109. CAMPI M, Peters GW, Toczydlowska D
    Ataxic speech disorders and Parkinson's disease diagnostics via stochastic embedding of empirical mode decomposition.
    PLoS One. 2023;18:e0284667.
    >> Share

  110. ANWER DM, Gubinelli F, Kurt YA, Sarauskyte L, et al
    A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates.
    PLoS One. 2023;18:e0284480.
    >> Share

  111. ALLWRIGHT M, Mundell H, Sutherland G, Austin P, et al
    Machine learning analysis of the UK Biobank reveals IGF-1 and inflammatory biomarkers predict Parkinson's disease risk.
    PLoS One. 2023;18:e0285416.
    >> Share

  112. MACLAGAN LC, Marras C, Sewell IJ, Wu CF, et al
    Trends in health service use among persons with Parkinson's disease by rurality: A population-based repeated cross-sectional study.
    PLoS One. 2023;18:e0285585.
    >> Share

  113. HIRANO M, Samukawa M, Isono C, Nagai Y, et al
    The effects of safinamide on dysphagia in Parkinson's disease.
    PLoS One. 2023;18:e0286066.
    >> Share

  114. DAS J, Barry G, Walker R, Vitorio R, et al
    The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson's: Is the future digital?
    PLoS One. 2023;18:e0285100.
    >> Share

  115. ESCHWEILER M, McCrum C, Giannouli E
    A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
    PLoS One. 2023;18:e0286402.
    >> Share

  116. CHAND DA, Scadeng M, Dieriks BV
    Absolute quantification of neuromelanin in formalin-fixed human brains using absorbance spectrophotometry.
    PLoS One. 2023;18:e0288327.
    >> Share

  117. MARTINDALE JM, Sarva H, Martino D, Gilbert DL, et al
    Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders.
    PLoS One. 2023;18:e0288408.
    >> Share

  118. PARAJULI M, Amara AW, Shaban M
    Deep-learning detection of mild cognitive impairment from sleep electroencephalography for patients with Parkinson's disease.
    PLoS One. 2023;18:e0286506.
    >> Share

  119. SORRELL L, Leta V, Barnett A, Stevens K, et al
    Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
    PLoS One. 2023;18:e0285349.
    >> Share

  120. ZAMORA-URSULO MA, Perez-Becerra J, Tellez LA, Saderi N, et al
    Reversal of pathological motor behavior in a model of Parkinson's disease by striatal dopamine uncaging.
    PLoS One. 2023;18:e0290317.
    >> Share

  121. BRITO SAF, Scianni AA, Silveira BMF, Oliveira ERM, et al
    Effects of high-intensity respiratory muscle training on respiratory muscle strength in individuals with Parkinson's disease: Protocol of a randomized clinical trial.
    PLoS One. 2023;18:e0291051.
    >> Share

  122. CROOKS S, Carter G, Wilson CB, Wynne L, et al
    Exploring public perceptions and awareness of Parkinson's disease: A scoping review.
    PLoS One. 2023;18:e0291357.
    >> Share

  123. CHIU YS, Wu KJ, Yu SJ, Wu KL, et al
    Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.
    PLoS One. 2023;18:e0291927.
    >> Share

  124. BATTISTA L, Casali M, Brusa L, Radicati FG, et al
    Clinical assessment of a new wearable tool for continuous and objective recording of motor fluctuations and ON/OFF states in patients with Parkinson's disease.
    PLoS One. 2023;18:e0287139.
    >> Share

  125. VOLLSTEDT EJ, Madoev H, Aasly A, Ahmad-Annuar A, et al
    Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.
    PLoS One. 2023;18:e0292180.
    >> Share

  126. OKEMUO AJ, Gallagher D, Dairo YM
    Effects of rebound exercises on balance and mobility of people with neurological disorders: A systematic review.
    PLoS One. 2023;18:e0292312.
    >> Share

  127. GUTOWSKI T, Antkiewicz R, Szlufik S
    Machine learning with optimization to create medicine intake schedules for Parkinson's disease patients.
    PLoS One. 2023;18:e0293123.
    >> Share

  128. PADILHA C, Souza R, Grossl FS, Gauer APM, et al
    Physical exercise and its effects on people with Parkinson's disease: Umbrella review.
    PLoS One. 2023;18:e0293826.
    >> Share

  129. THANPRASERTSUK S, Phowthongkum P, Hopetrungraung T, Poorirerngpoom C, et al
    Levodopa-induced dyskinesia in early-onset Parkinson's disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand.
    PLoS One. 2023;18:e0293516.
    >> Share

  130. LEE SH, Chung KC
    USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.
    PLoS One. 2023;18:e0290371.
    >> Share

  131. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    >> Share

  132. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    >> Share

  133. SENA IG, Costa AVD, Santos IKD, Araujo DP, et al
    Feasibility and effect of high-intensity training on the progression of motor symptoms in adult individuals with Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293357.
    >> Share

  134. MAGANA JC, Deus CM, Baldellou L, Avellanet M, et al
    Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for A randomized controlled clinical trial.
    PLoS One. 2023;18:e0293774.
    >> Share

  135. MORADI VASTEGANI S, Khoshnam SE, Ghafouri S, Bakhtiari N, et al
    Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal alpha-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.
    PLoS One. 2023;18:e0294612.
    >> Share

  136. XIN G, Niu J, Tian Q, Fu Y, et al
    Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
    PLoS One. 2023;18:e0294984.
    >> Share

  137. HONG JT, Jung HK, Lee KJ, Gong EJ, et al
    Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study.
    PLoS One. 2023;18:e0295981.
    >> Share

  138. CHEN L, Xin G, He Y, Tian Q, et al
    Study of molecular patterns associated with ferroptosis in Parkinson's disease and its immune signature.
    PLoS One. 2023;18:e0295699.
    >> Share

  139. BORGHESI F, Mancuso V, Bruni F, Cremascoli R, et al
    Mental flexibility assessment: A research protocol for patients with Parkinson's Disease and Anorexia Nervosa.
    PLoS One. 2023;18:e0293921.
    >> Share

  140. MERCER HM, Nair AM, Ridgel A, Piontkivska H, et al
    Alterations in RNA editing in skeletal muscle following exercise training in individuals with Parkinson's disease.
    PLoS One. 2023;18:e0287078.
    >> Share

  141. HATTORI N, Kabata D, Asada S, Kanda T, et al
    Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline.
    PLoS One. 2023;18:e0269969.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016